Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community Health Centers | 2 | 2017 | 433 | 0.590 |
Why?
|
| Models, Organizational | 1 | 2015 | 586 | 0.440 |
Why?
|
| Fee-for-Service Plans | 1 | 2016 | 636 | 0.440 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 545 | 0.390 |
Why?
|
| Career Choice | 1 | 2015 | 722 | 0.370 |
Why?
|
| Program Development | 1 | 2015 | 1334 | 0.360 |
Why?
|
| Health Care Reform | 3 | 2015 | 1267 | 0.350 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 908 | 0.340 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 949 | 0.320 |
Why?
|
| Delivery of Health Care | 7 | 2017 | 4466 | 0.300 |
Why?
|
| Curriculum | 2 | 2015 | 3114 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 2099 | 0.240 |
Why?
|
| Depressive Disorder | 5 | 2002 | 3893 | 0.230 |
Why?
|
| Delirium | 4 | 2019 | 1314 | 0.210 |
Why?
|
| Health Planning Organizations | 1 | 2019 | 13 | 0.200 |
Why?
|
| Nitroimidazoles | 1 | 2020 | 104 | 0.200 |
Why?
|
| Dominance, Cerebral | 2 | 2000 | 667 | 0.190 |
Why?
|
| Primary Health Care | 2 | 2015 | 4407 | 0.190 |
Why?
|
| Aging | 6 | 2010 | 8222 | 0.170 |
Why?
|
| Mood Disorders | 2 | 2003 | 1104 | 0.170 |
Why?
|
| Frontal Lobe | 2 | 2002 | 1432 | 0.170 |
Why?
|
| Depressive Disorder, Major | 5 | 2007 | 4299 | 0.170 |
Why?
|
| Organizational Objectives | 1 | 2019 | 448 | 0.160 |
Why?
|
| Geriatric Psychiatry | 3 | 2001 | 67 | 0.160 |
Why?
|
| Advanced Practice Nursing | 1 | 2015 | 13 | 0.150 |
Why?
|
| Alzheimer Disease | 5 | 1999 | 6626 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2002 | 6389 | 0.140 |
Why?
|
| Ebolavirus | 1 | 2016 | 233 | 0.140 |
Why?
|
| England | 1 | 2015 | 524 | 0.130 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2020 | 830 | 0.120 |
Why?
|
| Health Facilities | 1 | 2016 | 410 | 0.120 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 4928 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 398 | 0.110 |
Why?
|
| Epidemics | 1 | 2016 | 490 | 0.110 |
Why?
|
| Health Resources | 1 | 2017 | 931 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2002 | 2981 | 0.100 |
Why?
|
| Depression | 3 | 2000 | 6805 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 1782 | 0.100 |
Why?
|
| Brain | 6 | 2002 | 24202 | 0.100 |
Why?
|
| Fluphenazine | 1 | 1988 | 37 | 0.100 |
Why?
|
| Psychiatry | 3 | 2007 | 1502 | 0.090 |
Why?
|
| Social Behavior Disorders | 1 | 1988 | 102 | 0.090 |
Why?
|
| Anti-Anxiety Agents | 1 | 1990 | 398 | 0.080 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2007 | 133 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2007 | 33186 | 0.080 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 1140 | 0.080 |
Why?
|
| Atrophy | 3 | 2002 | 1447 | 0.080 |
Why?
|
| Health Expenditures | 1 | 1999 | 2154 | 0.080 |
Why?
|
| Health Policy | 1 | 1999 | 2596 | 0.080 |
Why?
|
| Medicaid | 1 | 1999 | 2479 | 0.080 |
Why?
|
| Parietal Lobe | 2 | 2007 | 808 | 0.070 |
Why?
|
| Humans | 34 | 2020 | 686663 | 0.060 |
Why?
|
| Hospitals, General | 1 | 2007 | 699 | 0.060 |
Why?
|
| Mental Status Schedule | 2 | 1997 | 306 | 0.060 |
Why?
|
| Functional Laterality | 2 | 2007 | 2330 | 0.060 |
Why?
|
| Temporal Lobe | 2 | 2007 | 1646 | 0.060 |
Why?
|
| Boston | 1 | 2015 | 9534 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2007 | 666 | 0.060 |
Why?
|
| Mental Disorders | 6 | 2010 | 6378 | 0.050 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2002 | 256 | 0.050 |
Why?
|
| Aged | 19 | 2019 | 162271 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2010 | 1545 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2007 | 1118 | 0.050 |
Why?
|
| Medicare | 1 | 2016 | 5077 | 0.050 |
Why?
|
| Reference Values | 2 | 1997 | 5134 | 0.050 |
Why?
|
| Oxazoles | 1 | 2020 | 214 | 0.050 |
Why?
|
| Pennsylvania | 2 | 1991 | 651 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 272 | 0.040 |
Why?
|
| Comorbidity | 4 | 2019 | 10648 | 0.040 |
Why?
|
| Prefrontal Cortex | 2 | 1998 | 2006 | 0.040 |
Why?
|
| United States | 6 | 2016 | 65579 | 0.040 |
Why?
|
| Sierra Leone | 1 | 2016 | 148 | 0.040 |
Why?
|
| Homes for the Aged | 1 | 1999 | 260 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15083 | 0.040 |
Why?
|
| Budgets | 1 | 2017 | 217 | 0.040 |
Why?
|
| Haiti | 1 | 2017 | 514 | 0.040 |
Why?
|
| Organizations | 1 | 2016 | 153 | 0.040 |
Why?
|
| Health Services Research | 2 | 2001 | 1858 | 0.040 |
Why?
|
| Community Mental Health Services | 1 | 1999 | 405 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2010 | 3942 | 0.040 |
Why?
|
| Financing, Government | 1 | 2019 | 490 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 1446 | 0.030 |
Why?
|
| Neuropsychological Tests | 3 | 2007 | 6814 | 0.030 |
Why?
|
| California | 1 | 1999 | 1399 | 0.030 |
Why?
|
| Research | 2 | 2003 | 2061 | 0.030 |
Why?
|
| Female | 17 | 2019 | 375459 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 538 | 0.030 |
Why?
|
| Affect | 1 | 2002 | 1497 | 0.030 |
Why?
|
| Male | 16 | 2019 | 352465 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 1997 | 548 | 0.030 |
Why?
|
| Age of Onset | 1 | 2000 | 3373 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2002 | 1774 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2020 | 1248 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 1624 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2007 | 59331 | 0.030 |
Why?
|
| Nursing Homes | 1 | 1999 | 904 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2007 | 4303 | 0.030 |
Why?
|
| Hospitalization | 1 | 1991 | 9304 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 4253 | 0.030 |
Why?
|
| Dementia | 1 | 2002 | 1984 | 0.030 |
Why?
|
| Internship and Residency | 1 | 1989 | 5322 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 1485 | 0.030 |
Why?
|
| Psychometrics | 2 | 1991 | 2954 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2001 | 1575 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 16227 | 0.020 |
Why?
|
| Risk Factors | 5 | 2019 | 69278 | 0.020 |
Why?
|
| Poverty | 1 | 2020 | 2489 | 0.020 |
Why?
|
| Hospitals, University | 1 | 1989 | 597 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2007 | 200 | 0.020 |
Why?
|
| Hospitals, Psychiatric | 1 | 2007 | 339 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8920 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1713 | 0.020 |
Why?
|
| Prevalence | 2 | 2019 | 14744 | 0.020 |
Why?
|
| Cognition | 1 | 2002 | 5582 | 0.020 |
Why?
|
| Forecasting | 2 | 2007 | 2956 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1988 | 986 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 1965 | 358 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1990 | 1040 | 0.020 |
Why?
|
| Middle Aged | 6 | 2003 | 216468 | 0.020 |
Why?
|
| Education | 2 | 2001 | 554 | 0.020 |
Why?
|
| Health Personnel | 1 | 2016 | 2837 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2000 | 21684 | 0.010 |
Why?
|
| Salivation | 1 | 1961 | 26 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 13444 | 0.010 |
Why?
|
| Electroconvulsive Therapy | 1 | 1965 | 400 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 2 | 2007 | 2701 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 1418 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1991 | 2445 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1961 | 220 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 2464 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1991 | 2596 | 0.010 |
Why?
|
| Population Dynamics | 1 | 2001 | 311 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 60991 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39737 | 0.010 |
Why?
|
| Placebos | 1 | 2002 | 1791 | 0.010 |
Why?
|
| Aggression | 1 | 2002 | 757 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1997 | 21640 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 67320 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 25703 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 38732 | 0.010 |
Why?
|
| Memory | 1 | 1965 | 2120 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1988 | 7791 | 0.010 |
Why?
|
| Age Factors | 2 | 2003 | 19295 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 1999 | 764 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 5182 | 0.010 |
Why?
|
| Age Distribution | 1 | 1999 | 2963 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1999 | 1489 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 1999 | 1254 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 8070 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1992 | 411 | 0.010 |
Why?
|
| Child | 1 | 2017 | 71361 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 3875 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 11866 | 0.010 |
Why?
|
| Decision Making | 1 | 2001 | 3865 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 4998 | 0.000 |
Why?
|
| Thalamus | 1 | 1992 | 952 | 0.000 |
Why?
|
| Corpus Striatum | 1 | 1992 | 1275 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1992 | 1420 | 0.000 |
Why?
|
| Body Height | 1 | 1991 | 1641 | 0.000 |
Why?
|
| Research Design | 1 | 1999 | 5835 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 49071 | 0.000 |
Why?
|
| Body Weight | 1 | 1991 | 4804 | 0.000 |
Why?
|
| Brain Ischemia | 1 | 1992 | 3150 | 0.000 |
Why?
|
| Hypertension | 1 | 1992 | 7941 | 0.000 |
Why?
|
| Algorithms | 1 | 1991 | 13500 | 0.000 |
Why?
|
| Adult | 2 | 1991 | 211400 | 0.000 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_